Proton pump inhibitors and risk of gastric cancer: a population-based cohort study

Proton pump inhibitor (PPI) use leads to hypergastrinaemia, which has been associated with gastrointestinal neoplasia. We evaluated the association between PPI use and risk of gastric cancer using population-based health-care registers in North Jutland, Denmark, during 1990–2003. We compared inciden...

Descripción completa

Detalles Bibliográficos
Autores principales: Poulsen, A H, Christensen, S, McLaughlin, J K, Thomsen, R W, Sørensen, H T, Olsen, J H, Friis, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694435/
https://www.ncbi.nlm.nih.gov/pubmed/19352380
http://dx.doi.org/10.1038/sj.bjc.6605024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694435/
https://www.ncbi.nlm.nih.gov/pubmed/19352380
http://dx.doi.org/10.1038/sj.bjc.6605024

Ejemplares similares